Clinical Trials Logo

Back Pain Lower Back Chronic clinical trials

View clinical trials related to Back Pain Lower Back Chronic.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01865539 Terminated - Clinical trials for Back Pain Lower Back Chronic

Efficacy of Foot Orthotics in Veterans With Chronic Lower Back Pain

Start date: May 2013
Phase: N/A
Study type: Interventional

A randomized sham controlled trial evaluating the efficacy of the use of custom foot orthotics in veterans suffering from chronic lower back pain. The current study hypothesizes that those veterans with chronic lower back pain who receive the custom foot orthotics will show greater improvements in pain and disability associated with the chronic lower back pain than those who receive the sham orthotic.

NCT ID: NCT01389999 Terminated - Clinical trials for Back Pain Lower Back Chronic

Validation of the French Version of the Back Belief Questionnaire

BBQ
Start date: January 2012
Phase: N/A
Study type: Observational

The goal of this study is to carry out a transcultural validation of the Back Belief Questionnaire in order to assess its appropriateness for French-speaking populations.

NCT ID: NCT01125917 Terminated - Clinical trials for Back Pain Lower Back Chronic

Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

Start date: June 2004
Phase: Phase 3
Study type: Interventional

The purpose of the extension phase is to evaluate the long-term safety and tolerability of buprenorphine transdermal system (BTDS). Subjects begin the extension phase on BTDS 5 mcg/h and may up- or down-titrate the dose [up to BTDS 20 micrograms (mcg) / hour (h)] depending on adequate pain relief and tolerability.

NCT ID: NCT00313014 Terminated - Clinical trials for Back Pain Lower Back Chronic

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

Start date: February 2004
Phase: Phase 3
Study type: Interventional

The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (BTDS) 20 in comparison to the buprenorphine transdermal system (BTDS) 5 and oxycodone immediate-release in subjects with moderate to severe low back pain currently treated with oral opioids. The double-blind treatment intervention duration is 12 weeks during which time supplemental analgesic medication (acetaminophen, ibuprofen) will be provided to all subjects in addition to study drug.